Alaunos Therapeutics Inc (STU:WEK)
€ 1.66 0 (-4.82%) Market Cap: 338.23 Mil Enterprise Value: 276.94 Mil PE Ratio: 0 PB Ratio: 1.04 GF Score: 54/100

Q1 2022 Alaunos Therapeutics Inc Earnings Call Transcript

May 16, 2022 / 12:30PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Alaunos Therapeutics' First Quarter 2022 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Mr. Alex Lobo, Investor Relations. Mr. Lobo, the floor is yours.

Alex Lobo

Good morning. and welcome to the Alaunos Therapeutics First Quarter 2022 Financial Results Conference Call and Audio Webcast.

With me today is Kevin Boyle Senior, Chief Executive Officer; Drew Deniger, Vice President of Research and Development; and Mike Wong, Vice President of Finance.

Earlier this morning, Alaunos issued a press release announcing financial results for the 3 months ended March 31, 2022. We encourage everyone to read today's press release as well as the Alaunos quarterly report on Form 10-Q for the quarter ended March 31, 2022, which was filed this morning with the SEC.

The company's press release and quarterly report will also be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot